SCHEDULE 13G/A: AdvisorShares Trust Divests Entire Stake in InMed Pharmaceuticals, Files Amended 13G

AdvisorShares Trust has filed an amended Schedule 13G, disclosing that it no longer holds any beneficial ownership in InMed Pharmaceuticals Inc.

Summary

• AdvisorShares Trust, a Delaware-based entity, filed an Amendment No. 1 to its Schedule 13G regarding its holdings in InMed Pharmaceuticals Inc.
• The filing indicates that as of March 31, 2025, AdvisorShares Trust beneficially owns 0.00 shares of InMed Pharmaceuticals Inc.'s Common Shares, representing 0% of the class.
• This amendment signifies that AdvisorShares Trust has reduced its stake below the reporting threshold or completely divested its holdings.
• The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 5

Explanation: The document is a neutral, factual disclosure of a change in beneficial ownership by an institutional investor, with no direct positive or negative implications for the issuer's operational or financial performance.

Future Outlook

No forward-looking statements or guidance regarding InMed Pharmaceuticals Inc. were provided in this beneficial ownership disclosure.

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11." (Certification by AdvisorShares Trust)

Industry Context

This filing is a routine regulatory disclosure by an institutional investor, AdvisorShares Trust, indicating a change in its passive investment position in InMed Pharmaceuticals Inc. Such changes are common in the investment management industry as funds adjust their portfolios.

Stakeholder Impact

• Shareholders of InMed Pharmaceuticals Inc. will note that AdvisorShares Trust no longer holds a reportable beneficial ownership stake in the company.

Key Dates

Keywords

InMed Pharmaceuticals, AdvisorShares Trust, Schedule 13G, beneficial ownership, common shares, SEC filing, divestment